{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:02Z","timestamp":1790677382937,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12,15]]},"DOI":"10.1093\/hmg\/ddn290","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T20:34:07Z","timestamp":1220992447000},"page":"3876-3886","source":"Crossref","is-referenced-by-count":47,"title":["Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II"],"prefix":"10.1093","volume":"17","author":[{"given":"Gaelle","family":"Douillard-Guilloux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Takikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,9,9]]},"reference":[{"key":"key\n\t\t\t\t20170503070326_DDN290C1","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1016\/S0021-9258(17)39477-2","article-title":"Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II","volume":"260","author":"Reuser","year":"1985","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170503070326_DDN290C2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"key\n\t\t\t\t20170503070326_DDN290C3","first-page":"53","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"7","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170503070326_DDN290C4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","article-title":"Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503070326_DDN290C5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2005-837543","article-title":"Enzyme replacement therapy in classical infantile Pompe disease: results of a ten-month follow-up study","volume":"36","author":"Klinge","year":"2005","journal-title":"Neuropediatrics"},{"key":"key\n\t\t\t\t20170503070326_DDN290C6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1010383421286","article-title":"Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk","volume":"24","author":"Van den Hout","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170503070326_DDN290C7","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"key\n\t\t\t\t20170503070326_DDN290C8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-007-0519-9","article-title":"Glycogen storage disease types I and II: treatment updates","volume":"30","author":"Koeberl","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170503070326_DDN290C9","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1007\/BF02680006","article-title":"Enzyme therapy for Pompe disease: from science to industrial enterprise","volume":"161","author":"Reuser","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"key\n\t\t\t\t20170503070326_DDN290C10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170503070326_DDN290C11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1525-0016(02)90716-1","article-title":"Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme","volume":"6","author":"Raben","year":"2002","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170503070326_DDN290C12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170503070326_DDN290C13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/mus.20896","article-title":"Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease","volume":"37","author":"Drost","year":"2008","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170503070326_DDN290C14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ymthe.2005.01.012","article-title":"Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170503070326_DDN290C15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170503070326_DDN290C16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.2008.010","article-title":"Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice","volume":"19","author":"Ziegler","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"key\n\t\t\t\t20170503070326_DDN290C17","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.gt.3302314","article-title":"Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model","volume":"11","author":"Xu","year":"2004","journal-title":"Gene Ther."},{"key":"key\n\t\t\t\t20170503070326_DDN290C18","first-page":"1824","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease","volume":"52","author":"Fukuda","year":"2005","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C19","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1182\/blood-2007-02-075960","article-title":"Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement","volume":"110","author":"Elstein","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170503070326_DDN290C20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170503070326_DDN290C21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/bst0290537","article-title":"Regulation of glycogen synthesis in human muscle cells","volume":"29","author":"Yeaman","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"key\n\t\t\t\t20170503070326_DDN290C23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbagen.2004.03.017","article-title":"Glycogenin: the primer for mammalian and yeast glycogen synthesis","volume":"1673","author":"Lomako","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170503070326_DDN290C24","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1073\/pnas.92.19.8535","article-title":"In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis","volume":"92","author":"Shulman","year":"1995","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170503070326_DDN290C25","doi-asserted-by":"crossref","first-page":"E757","DOI":"10.1152\/ajpendo.00532.2005","article-title":"Glycogenin, proglycogen, and glycogen biogenesis: what\u2019s the story?","volume":"290","author":"Katz","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170503070326_DDN290C26","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.gt.3302335","article-title":"Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection","volume":"11","author":"Richard","year":"2004","journal-title":"Gene Ther."},{"key":"key\n\t\t\t\t20170503070326_DDN290C27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ncb1231","article-title":"Atrophy of S6K1(\u2212\/\u2212) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control","volume":"7","author":"Ohanna","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C28","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1152\/ajpendo.00100.2005","article-title":"Increases in glycogenin and glycogenin mRNA accompany glycogen resynthesis in human skeletal muscle","volume":"289","author":"Shearer","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170503070326_DDN290C29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1432-1033.1997.t01-1-00147.x","article-title":"Glycogen biogenesis in rat 1 fibroblasts expressing rabbit muscle glycogenin","volume":"245","author":"Skurat","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"key\n\t\t\t\t20170503070326_DDN290C30","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1073\/pnas.1534787100","article-title":"De novo synthesis of bacterial glycogen: agrobacterium tumefaciens glycogen synthase is involved in glucan initiation and elongation","volume":"100","author":"Ugalde","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170503070326_DDN290C31","first-page":"369","article-title":"Alkylglycosides as artificial primers for glycogen biosynthesis","volume":"43","author":"Meezan","year":"1997","journal-title":"Cell Mol. Biol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C32","doi-asserted-by":"crossref","first-page":"26554","DOI":"10.1074\/jbc.271.43.26554","article-title":"Initiation of glycogen synthesis in yeast. Requirement of multiple tyrosine residues for function of the self-glucosylating Glg proteins in vivo","volume":"271","author":"Mu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170503070326_DDN290C33","first-page":"1","article-title":"Fine structural aspects of the mobilization of hepatic glycogen. I. Acceleration of glycogen breakdown","volume":"63","author":"Kotoulas","year":"1971","journal-title":"Am. J. Pathol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C34","first-page":"23","article-title":"Fine structural aspects of the mobilization of hepatic glycogen. II. Inhibition of glycogen breakdown","volume":"63","author":"Kotoulas","year":"1971","journal-title":"Am. J. Pathol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/auto.2984","article-title":"Autophagy and lysosomes in Pompe disease","volume":"2","author":"Fukuda","year":"2006","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20170503070326_DDN290C36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2249.2008.03602.x","article-title":"Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model","volume":"152","author":"Joseph","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C37","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/522236","article-title":"Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance","volume":"81","author":"Sun","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170503070326_DDN290C38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.56.12.1739","article-title":"Surprises of genetic engineering: a possible model of polyglucosan body disease","volume":"56","author":"Raben","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170503070326_DDN290C39","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1128\/MCB.24.16.7179-7187.2004","article-title":"Abnormal cardiac development in the absence of heart glycogen","volume":"24","author":"Pederson","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"key\n\t\t\t\t20170503070326_DDN290C40","doi-asserted-by":"crossref","first-page":"17260","DOI":"10.1074\/jbc.M410448200","article-title":"Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise","volume":"280","author":"Pederson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170503070326_DDN290C41","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.2337\/diabetes.54.12.3466","article-title":"Glucose metabolism in mice lacking muscle glycogen synthase","volume":"54","author":"Pederson","year":"2005","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170503070326_DDN290C42","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.pmed.0050025","article-title":"New insights into impaired muscle glycogen synthesis","volume":"5","author":"Groop","year":"2008","journal-title":"PLoS Med."},{"key":"key\n\t\t\t\t20170503070326_DDN290C43","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","article-title":"Cardiomyopathy and exercise intolerance in muscle glycogen storage disease","volume":"357","author":"Kollberg","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170503070326_DDN290C44","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1528-1167.2007.01074.x","article-title":"Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase\/miglustat combination","volume":"48","author":"Capablo","year":"2007","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t20170503070326_DDN290C45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood.V97.1.327","article-title":"Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation","volume":"97","author":"Jeyakumar","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170503070326_DDN290C46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/17\/24\/3876\/14138023\/ddn290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T01:44:17Z","timestamp":1631756657000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddn290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,9]]},"references-count":46,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2008,9,9]]},"published-print":{"date-parts":[[2008,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddn290","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9,9]]}}}